文献

J-GLOBAL ID：202002234228968152   整理番号：20A2441190

小児,思春期および若年成人癌の生存者のためのCOVID-19に関するガイダンス: 小児癌ガイドライングループの国際後期効果からの声明【JST・京大機械翻訳】

Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group

著者 (48件)： Verbruggen Lisanne C. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Wang Yuehan (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Armenian Saro H. (Department of Population Sciences, City of Hope National Medical Center, Duarte, California, USA) ,  Ehrhardt Matthew J. (Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  Ehrhardt Matthew J. (Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  van der Pal Helena J.H. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  van Dalen Elvira C. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  van As Jorrit W. (Cochrane Childhood Cancer, Amsterdam, the Netherlands) ,  Bardi Edit (St Anna Childrens Hospital, Vienna, Austria) ,  Bardi Edit (Kepler University Clinic, Med Campus IV, Linz, Austria) ,  Baust Katja (Department for Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany) ,  Berger Claire (Department for Pediatric Hematology and Oncology CHU Nord, University Hospital Saint-Etienne, Saint-Priest en Jarez, France) ,  Berger Claire (Epidemiology of Childhood and Adolescent Cancers, CRESS, INSERM, UMR 1153, Paris Descartes University, Villejuif, France) ,  Castagnola Elio (Infectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy) ,  Devine Katie A. (Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, New Jersey, USA) ,  Gebauer Judith (Institute for Endocrinology and Diabetes, University of Luebeck, Ratzeburger Allee 160, Luebeck, 23562, Germany) ,  Marchak Jordan Gilleland (Emory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA) ,  Glaser Adam W. (Department of Paediatric Oncology, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK) ,  Groll Andreas H. (Infectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University Children’s Hospital, Muenster, Germany) ,  Haeusler Gabrielle M. (NHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia) ,  Haeusler Gabrielle M. (Department of Infectious Diseases, Peter MacCallum Cancer Centre and Royal Children’s Hospital, Parkville, Victoria, Australia) ,  Haeusler Gabrielle M. (Murdoch Children’s Research Institute, Parkville, Victoria, Australia) ,  den Hartogh Jaap (Dutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, the Netherlands) ,  Haupt Riccardo (Epidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy) ,  Hjorth Lars (Lund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden) ,  Kato Miho (Department of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children’s Medical Center, Okinawa, Japan) ,  Kepak Tomas (University Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University, Brno, Czech Republic) ,  Koopman Maria M.W. (Rianne) (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Langer Thorsten (University Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Ratzeburger Allee 160, Luebeck, 23562, Germany) ,  Maeda Miho (Department of Pediatrics, Nippon Medical School, Tokyo, Japan) ,  Michel Gisela (Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland) ,  Muraca Monica (Epidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini, Genova, Italy) ,  Nathan Paul C. (The Hospital for Sick Children, Toronto, Canada) ,  van den Oever Selina R. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Pavasovic Vesna (Department of Malignant Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK) ,  Sato Satomi (St. Luke’s International University, Tokyo, Japan) ,  Schulte Fiona (Department of Oncology, Division of Psychosocial Oncology, University of Calgary, Calgary, AB, Canada) ,  Sung Lillian (Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada) ,  Tissing Wim (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Tissing Wim (Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands) ,  Uyttebroeck Anne (Department of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium) ,  Mulder Renee L. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Kuehni Claudia (Childhood Cancer Registry (ChCR), Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland) ,  Skinner Roderick (Department of Paediatric and Adolescent Haematology/Oncology, Great North Children’s Hospital, and Clinical and Translational Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK) ,  Hudson Melissa M. (Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  Hudson Melissa M. (Department of Oncology, St. Jude Children’s Research Hospital, Memphis, Tennessee, USA) ,  Kremer Leontien C.M. (Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands) ,  Kremer Leontien C.M. (Amsterdam University Medical Center, Department of Pediatrics, Amsterdam, the Netherlands)
資料名： Pediatric Blood & Cancer  (Pediatric Blood & Cancer)
巻： 67  号： 12  ページ： e28702  発行年： 2020年 
JST資料番号： W2716A  ISSN： 1545-5009  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： アメリカ合衆国 (USA)  言語： 英語 (EN)

抄録/ポイント： 小児,青年および若年成人(CAYA)癌生存者は,COVID-19の重症コースのリスクがある。CAYA癌生存者におけるCOVID-19の臨床経過,または追加の予防対策が保証されるかどうかについてはほとんど知られていない。著者らは,CAYA癌生存者におけるCOVID-19の重症コースに対するリスクと関連する因子/条件に関する証拠に関する既存の証拠と世界的な推奨を要約するために,小児癌ガイドライン調和グループ(IGHG)の国際後期効果の中での作業グループを確立し,COVID-19に関するヘルスケア実務者とCAYA癌生存者のためのガイダンスを提供するコンセンサス状態を開発した。Copyright 2020 Wiley Publishing Japan K.K. All rights reserved. Translated from English into Japanese by JST.【JST・京大機械翻訳】

シソーラス用語： 子供 ,  病状経過 ,  *思春期 ,  *生存者 ,  *小児癌 ,  *若年成人 ,  がん生存者

著者キーワード (3件)： 小児思春期と若年成人(CAYA)癌生存者 ,  COVID-19 ,  癌治療の後期効果

分類 (4件)： 血液の腫よう  (GK04000M) ,  抗腫よう薬の臨床への応用  (GW16020L) ,  腫ようの薬物療法  (GE03032C) ,  臨床腫よう学一般  (GE03010Y)

タイトルに関連する用語 (9件)： 小児 ,  若年成人 ,  癌 ,  生存 ,  ガイダンス ,  小児癌 ,  ガイドライン ,  グループ ,  声明